Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06725030 · ClinicalTrials.gov registry record
A Post-market, Real-world Experience: Expanding Access to Care by Incorporating the Symani® Surgical System and Enabling Surgeons
A clinical trial of Lymphedema and Free Tissue Transfer, sponsored by MMI (Medical Microinstruments, Inc.).
- Recruiting
- Registry status
- 455
- Enrollment target
- 4
- Study locations
NCT06725030 is a study of Lymphedema and Free Tissue Transfer that is actively recruiting participants, run by MMI (Medical Microinstruments, Inc.). The registered enrollment target is 455 participants, below the 9,286-participant average among 34 other Lymphedema trials with a reported enrollment target (95% lower). The trial reports 4 study locations across 4 states.
The verdict
NCT06725030, a study of Lymphedema and Free Tissue Transfer, is actively recruiting participants, sponsored by MMI (Medical Microinstruments, Inc.).
- RECRUITING
- Registry status
- 455 participants
- Enrollment target
- 4
- Study locations
Study Summary
The objective of this study is to evaluate the Symani System's safety and effectiveness for microsurgical anastomosis during free tissue transfer surgery and lymphovenous anastomosis surgery. The primary endpoints are: * Effectiveness- Rate of intraoperative anastomosis patency at first attempt. * Safety- Freedom from device-related adverse events. Participants will receive treatment as standard of care and be asked to: * Allow the researchers to access and use their information. * If participants are undergoing a lymphedema procedure, they will be asked to undergo a questionnaire as part of the study. * Participants will be asked to comply with the follow-up visits and complete all study procedures/questionnaires as outlined in the protocol.
Conditions Studied
Interventions
- DEVICE Symani Surgical System
Study Locations (4)
California
- Cedars Sinai Medical Center - Beverly Hills
Connecticut
- Yale New Haven Hospital - New Haven
Florida
- Tampa General Hospital - Tampa
Ohio
- Cleveland Clinic - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 455 participants |
| Start Date | 2025-09-22 |
| Est. Completion | 2027-12-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06725030
The ClinicalTrials.gov registry entry for NCT06725030 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 455 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 9,286-participant average among 34 other Lymphedema trials with a reported enrollment target (95% lower). The listed sponsor is MMI (Medical Microinstruments, Inc.), which has 2 total studies on file at ClinicalTrials.gov.
The record links to 5 conditions, with Lymphedema appearing as the primary indexed condition, and to 1 intervention - of which Symani Surgical System is the first listed.
NCT06725030 reports 4 study locations spanning 4 distinct geographic areas - top geographies include California, Connecticut, Florida.
Frequently Asked Questions
What is clinical trial NCT06725030 about?
NCT06725030 is a clinical study titled "A Post-market, Real-world Experience: Expanding Access to Care by Incorporating the Symani® Surgical System and Enabling Surgeons". The objective of this study is to evaluate the Symani System's safety and effectiveness for microsurgical anastomosis during free tissue transfer surgery and lymphovenous anastomosis surgery. The primary endpoints are: * Effectiveness- Rate of intraoperative anastomosis patency at first attempt. *...
What is the current status of trial NCT06725030?
This trial is currently recruiting. The enrollment target is 455 participants. The study started on 2025-09-22. Estimated completion is 2027-12-01.
What conditions does trial NCT06725030 study?
This clinical trial studies the following conditions: Lymphedema, Free Tissue Transfer, Anastomosis, Surgical, Open Surgery, Microsurgery.
What interventions are being tested in trial NCT06725030?
The interventions under investigation include: Symani Surgical System (DEVICE).
Who is sponsoring clinical trial NCT06725030?
This trial is sponsored by MMI (Medical Microinstruments, Inc.), which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06725030 being conducted?
This trial has 4 study locations across California, Connecticut, Florida, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lymphedema
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Lymphedema Surveillance Study
RECRUITING
-
Efficacy of GLP-1 Receptor Agonists in Treating Upper and Lower Extremity Lymphedema
RECRUITING · Early Phase 1
-
Reversing External-beam Radiotherapy-associated Fibrosis Syndrome: an Interventional Bayesian Adaptive Randomized-controlled Orphan Drug Platform Trial for Orodental Sequelae (Reverse-fibrose)
RECRUITING · Phase 2
-
A Real-World Registry of Chronic Wounds and Ulcers
RECRUITING
-
A Study of a Comprehensive Prevention Program to Reduce Lymphedema After Axillary Lymph Node Dissection in People With Breast Cancer
RECRUITING · Phase 3
-
Lymphedema Prevention Through Immediate Lymphatic Reconstruction (LILY) Trial.
RECRUITING · Phase 2
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.